[GIERAS] Inflamación y enfermedades reumáticas autoinmunes sistémicas
Publications (39) Publications in which a researcher has participated
2025
-
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry
Arthritis research & therapy, Vol. 27, Núm. 1, pp. 5
2024
-
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Lupus Science and Medicine, Vol. 11, Núm. 1
2023
2022
-
Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison with Adult Patients Analysis from a Multicentric Cohort in Spain
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E195-E202
2021
-
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up
Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915
-
Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain
Reumatologia Clinica, Vol. 17, Núm. 5, pp. 245-249
-
Impact of biological therapies on the immune response after pneumococcal vaccination in patients with autoimmune inflammatory diseases
Vaccines, Vol. 9, Núm. 3, pp. 1-12
-
Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey
Joint Bone Spine, Vol. 88, Núm. 4
2019
-
Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study
Medicina Clinica, Vol. 153, Núm. 10, pp. 380-386
-
Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study
Rheumatology International, Vol. 39, Núm. 12, pp. 2015-2024
-
Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry
International Journal of Rheumatic Diseases, Vol. 22, Núm. 8, pp. 1393-1401
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2018
-
Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis
Reumatologia Clinica, Vol. 14, Núm. 6, pp. 320-333
-
Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence
Rheumatology International, Vol. 38, Núm. 12, pp. 2289-2296
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656
-
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 362-375
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
-
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain
Rheumatology International, Vol. 37, Núm. 11, pp. 1853-1861
-
Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis
Reumatologia Clinica, Vol. 13, Núm. 6, pp. 331-337
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1